Durable Remission Seen in Two CLL Patients After CAR T Cell Therapy

Long-term chimeric antigen receptor (CAR) T cell signaling and persistence has been demonstrated at more than 10 years after infusion in two chronic lymphocytic leukemia (CLL) patients.

Related Keywords

University Of Pennsylvania ,Pennsylvania ,United States ,Philadelphia ,J Joseph Melenhorst , ,Novartis ,Healthday News ,Joseph Melenhorst ,